Telbivudine for the treatment of chronic hepatitis B in HBeAg-positive patients in China: a health economic analysis

BACKGROUND: Nucleos(t)ide analogs (NUCs) are the standard of care for chronic hepatitis B (CHB). The present analysis aimed to determine the cost effectiveness of NUCs in Chinese healthcare settings. METHODS: A Markov model was used to simulate two therapeutic strategies for a hypothetical patient c...

Descripción completa

Detalles Bibliográficos
Autores principales: Banerjee, S., Gunda, P., Drake, R. F., Hamed, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052247/
https://www.ncbi.nlm.nih.gov/pubmed/27777855
http://dx.doi.org/10.1186/s40064-016-3404-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052247/
https://www.ncbi.nlm.nih.gov/pubmed/27777855
http://dx.doi.org/10.1186/s40064-016-3404-x

Ejemplares similares